← signals
2026-07-27·ASML·prediction market consensus
medup

Multiple prediction markets on Manifold Markets as of July 27, 2026 collectively indicate a bullish outlook for ASML.

Multiple prediction markets on Manifold Markets as of July 27, 2026 collectively indicate a bullish outlook for ASML.

window 30devidence 11confidence score 71price ASML $1757.09

confidence score

Usable evidence: enough corroboration to publish, with 1 independent source class.

71
medium confidence1 independent source classesmarketmedium high without independent sourcespasses publish gate
priced-in check

ASML has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-07-247d n/a45d n/a90d +21%yahoo

signal brief

Multiple prediction markets on Manifold Markets as of July 27, 2026 collectively indicate a bullish outlook for ASML. Key signals include:

  • Monopoly position: 79.92% probability ASML remains the only EUV producer through 2026, and 70.76% through 2027 (Sources: 2, 4).
  • Revenue growth: 83.77% probability ASML's revenue increases every year for the next 5 years (Source: 3).
  • Export controls: 50.00% probability the US forces ASML to halt exports to China before 2029, and 43.06% of a Cymer cutoff before 2030 (Sources: 8, 5).
  • China EUV: Only 15.54% probability China has an ASML EUV machine, and 6.28% that one was sold in 2023 (Sources: 1, 10).
  • Domestic competition: 56.45% probability China invents a domestic EUV by 2030, but not imminent (Source: 7).
  • Other: Low probabilities for CEO crime (11.23%) and ASML stock reaching $1700 in 2024 (1.00%) (Sources: 6, 11).

What the sources said:

  • Source [3]: "Will ASML's revenue increase every year for the next 5 years? YES=83.77%"
  • Source [2]: "Will ASML remain the world’s only producer of EUV machines until the end of 2026? YES=79.92%"
  • Source [1]: "Does China have an ASML EUV machine? YES=15.54%"
  • Source [8]: "Will the US force ASML to halt exports to China before 2029? YES=50.00%"

The consensus paints a picture of sustained ASML dominance, limited near-term Chinese capability, and manageable regulatory risk. This supports an upward bias for ASML's competitive position and financial outlook.

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.